ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D01BA02 | G | Terbinafine HCl - 250mg | 8341 | 97115/1 | BODERM | 250mg | 15 | Tablet | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 749,992 L.L | 23.08 | A2 | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D01BA02 | B | Terbinafine HCl - 250mg | 856 | 27739 | LAMISIL | 250mg | 14 | Tablet, scored | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharma Produktions GmbH, Wehr | Germany | 813,025 L.L | 23.08 | A2 | Novartis Pharma AG | Switzerland | 2/5/2024 | 0 |
D01BA02 | G | Terbinafine HCl - 250mg | 5589 | 221407/08 | APO-TERBINAFINE | 250mg | 30 | Tablet | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 1,409,691 L.L | 23.08 | A2 | Apotex Inc | Canada | 2/5/2024 | 0 |
D01BA02 | G | Terbinafine HCl - 250mg | 7155 | 194031/05 | LAMIFEN | 250mg | 7 | Tablet | Oral | The Lebanese Pharmacists SAL | Jamjoum Pharmaceuticals | Saudi Arabia | 245,923 L.L | 23.08 | A1 | Jamjoum Pharmaceuticals | Saudi Arabia | 2/5/2024 | 0 |
D01BA02 | G | Terbinafine HCl - 250mg | 4715 | 194150/05 | LAMINOX | 250mg | 14 | Tablet | Oral | Pharmaline S.A.L. | Pharmaline Licensed by Tripharma, Turkey | Lebanon | 725,675 L.L | 23.08 | A2 | 2/5/2024 | 0 | ||
D01BA02 | G | Terbinafine HCl - 250mg | 4361 | 208687/03 | TERAFAN | 250mg | 14 | Tablet, scored | Oral | Medapharm Healthcare SAL | Mediphar Laboratories | Lebanon | 725,675 L.L | 23.08 | A2 | 2/5/2024 | 0 |